Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Seeds, Inc. is an agricultural biotechnology company that operates as a subsidiary of Bayer (following Bayer's acquisition of Monsanto). Founded in 2004 by Monsanto, the company was established as a holding vehicle to acquire and manage regional seed companies across the United States, such as Channel Bio Corp and Fontanelle Hybrids. Its primary business involves the development, marketing, and distribution of corn and soybean seeds integrated with advanced biotechnological traits. By leveraging a network of regional brands, American Seeds provides farmers with localized seed products enhanced by large-scale R&D in genetics and crop protection. The company plays a significant role in the commercialization of genetically modified (GM) seed technologies within the North American agricultural market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Seeds.